Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Desoxyrhaponticin
Cat. No.:
OB0225LY-0021
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Desoxyrhaponticin is a compound derived from plants that controlling postprandial hyperglycemia in diabetes.
Synonym:
Deoxyrhapontin; Deoxyrhaponticin; 30197-14-9; (2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[(E)-2-(4-methoxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; 3,5-Dihydroxy-4'-methoxystilbene 3-O-beta-D-glucoside
CAS No.:
30197-14-9
Compound CID:
5316606
Formula:
C21H24O8
Formula Weight:
404.41
Specification
Relative Density:
1.433 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Desoxyrhaponticin can be used as fatty acid synthase(FAS) inhibitor to inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.
Library Information
Targets:
Metabolic enzymes
Receptors:
FAS
Pathways:
Apoptosis; Metabolism
Plate Number:
AOCL-1
Plate Location:
c2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 123.64 mM
